Home›People›Aman Mahajan
Aman Mahajan

Aman Mahajan

Director at Sensydia.

ExecutiveDirectorRoles at 2 startups
Updated Nov 8, 2026·Latest SEC filing Oct 19, 2026·Suggest an edit

About Aman Mahajan

Aman Mahajan is a venture partner at Colle Capital. He chairs a department and directs perioperative services for University of Pittsburgh Physicians and UPMC. He also holds UPMC’s endowed Peter and Eva Safar Professorship. He co-founded Sensydia. Sensydia builds systems that measure heart function without entering the body for offices, hospitals and clinics. He teaches a health care business course at UCLA Anderson School of Management.

He joined UCLA in 1994. Before moving to UPMC, he led UCLA’s anesthesiology and perioperative medicine department. He also held the Ronald L. Katz professorship in anesthesiology and bioengineering. He directed UCLA operative services and co-directed its cardiac arrhythmia program. His research examines sudden cardiac death, heart structure and function, and cardiac sensors. He has published more than 150 peer-reviewed papers. His UCLA training included a physiology doctorate focused on the heart’s electrical activity. He also holds an MBA and founded other medical technology startups. He sits on councils, boards and executive committees for several national scientific societies.

Experience

This experience comes from official bios, from Aman Mahajan's profile and from SEC filings. For roles taken from filings, the years are when the filings name Aman Mahajan in the role, so the role may have started earlier or lasted longer.

DGI Diploid Genomics Inc. Current
Co-Founder and Board of Directors
2026 – Present
Daymark Health, Inc. Current
Board of Directors
2025 – Present · Philadelphia, PA
University of Southern California Current
Associate Senior Vice President, Health Sciences Innovation, University of Southern California
2025 – Present
Keck School of Medicine of the University of Southern California Current
Professor, Anesthesiology and Population & Public Health
2025 – Present
Healthier Capital Current
Healthier Capital, Partner
2024 – Present
UPMC Current
Peter and Eva Safar Professorship
Senior Vice President, UPMC Enterprises (2020 – 2025)
2020 – Present
University of Pittsburgh Physicians/UPMC Current
department Chair and Director of Perioperative Services
Professor of Bioengineering and Professor of Biomedical Informatics (2018 – Present)
2018 – Present
Sensydia Corp Current
co-founder
Director
2016 – Present · Valencia, CA
Sensydia develops an AI-based system for real-time, noninvasive cardiac measurement in offices, hospitals and clinics.
Colle Capital Current
Venture partner
UCLA Anderson School of Management Current
UCLA Henry Samueli School of Engineering and Applied Science
Professor of Bioengineering
2013 – 2018
UCLA David Geffen School of Medicine
Executive Chair of the Department of Anesthesiology & Perioperative Medicine
Ronald L. Katz Professor of Anesthesiology and Bioengineering
UCLA Operative Services
Executive Director
UCLA Cardiac Arrhythmia Program
Co-Director

Key Colleagues at Startups

The people Aman Mahajan works with at each company, as listed on that company's latest Form D.

Sensydia Corp · Form D, Oct 19, 2026
Anthony Arnold
Anthony Arnold
President & CEO, director
KS
Kanav Saraf
Executive officer
WK
William Kaiser
Executive officer
Rusty Page
Rusty Page
President
EH
VG
DS
Derrick Sung
Director
Daymark Health, Inc. · Form D, Sep 3, 2025
PD
Paul Dufault
Executive officer
KM
RB
JB
Justin Bekelman
Chief Executive Officer and director

Sources

  1. SECSensydia Corp Form D, filed Oct 19, 2026
  2. SECDaymark Health, Inc. Form D, filed Sep 3, 2025